UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 30, 2005
SRA INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-31334 | 54-1360804 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
4300 Fair Lakes Court Fairfax, Virginia |
22033 | |
(Address of Principal Executive Offices) | (Zip Code) |
(Registrants telephone number, including area code): (703) 803-1500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
SECTION 1. REGISTRANTS BUSINESS AND OPERATIONS
ITEM 1.02. Termination of a Material Definitive Agreement.
On August 30, 2005, SRA International, Inc., (the Company) and its chairman, Ernst Volgenau, terminated a stock purchase agreement that required the Company to repurchase a limited number of shares from the chairmans estate upon his death. The Company had purchased term life insurance policies on its chairman to meet these repurchase obligations. The Company has terminated all related term life insurance policies.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SRA INTERNATIONAL, INC. | ||
Date: September 6, 2005 |
/S/ CHARLES G. CROTTY | |
Charles G. Crotty | ||
Vice President and Director, Corporate Compliance |